Compare Eli Lilly And Co (LLY) vs Plug Power Inc (PLUG) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

Plug Power (PLUG) trades at $2.14, down 0.47% on the day, reflecting ongoing investor concerns about profitability despite recent contract wins. The stock shows bearish technical signals with negative moving averages, while fundamentals reveal persistent losses with a -227.13% net income margin and negative cash flow. Recent news highlights a major 50MW Australian hydrogen project win, but operational challenges and dilution risks remain.

The outlook remains challenging with significant execution risks and cash burn, though analyst consensus suggests 36% upside to the $2.92 price target. Investment opportunity hinges on hydrogen adoption scaling faster than losses, while key risks include continued dilution, competitive pressure, and the company's ability to achieve profitability amid high debt levels.